177 related articles for article (PubMed ID: 30866954)
1. Chronic abdominal vagus stimulation increased brain metabolic connectivity, reduced striatal dopamine transporter and increased mid-brain serotonin transporter in obese miniature pigs.
Malbert CH; Genissel M; Divoux JL; Henry C
J Transl Med; 2019 Mar; 17(1):78. PubMed ID: 30866954
[TBL] [Abstract][Full Text] [Related]
2. Lower availability of midbrain serotonin transporter between healthy subjects with and without a family history of major depressive disorder - a preliminary two-ligand SPECT study.
Hsieh PC; Chen KC; Yeh TL; Lee IH; Chen PS; Yao WJ; Chiu NT; Chen CC; Liao MH; Yang YK
Eur Psychiatry; 2014 Sep; 29(7):414-8. PubMed ID: 24439516
[TBL] [Abstract][Full Text] [Related]
3. Obesity-Associated Alterations in Glucose Metabolism Are Reversed by Chronic Bilateral Stimulation of the Abdominal Vagus Nerve.
Malbert CH; Picq C; Divoux JL; Henry C; Horowitz M
Diabetes; 2017 Apr; 66(4):848-857. PubMed ID: 28082456
[TBL] [Abstract][Full Text] [Related]
4. Effects and mechanisms of auricular vagus nerve stimulation on high-fat-diet--induced obese rats.
Li H; Zhang JB; Xu C; Tang QQ; Shen WX; Zhou JZ; Chen JD; Wang YP
Nutrition; 2015; 31(11-12):1416-22. PubMed ID: 26429664
[TBL] [Abstract][Full Text] [Related]
5. Timing of caloric intake during weight loss differentially affects striatal dopamine transporter and thalamic serotonin transporter binding.
Versteeg RI; Schrantee A; Adriaanse SM; Unmehopa UA; Booij J; Reneman L; Fliers E; la Fleur SE; Serlie MJ
FASEB J; 2017 Oct; 31(10):4545-4554. PubMed ID: 28679529
[TBL] [Abstract][Full Text] [Related]
6. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An
Joling M; Vriend C; Raijmakers PGHM; van der Zande JJ; Lemstra AW; Berendse HW; Booij J; van den Heuvel OA
Neuroimage Clin; 2019; 22():101755. PubMed ID: 30884365
[TBL] [Abstract][Full Text] [Related]
7. Serotonin Transporter Binding in the Diencephalon Is Reduced in Insulin-Resistant Obese Humans.
Versteeg RI; Koopman KE; Booij J; Ackermans MT; Unmehopa UA; Fliers E; la Fleur SE; Serlie MJ
Neuroendocrinology; 2017; 105(2):141-149. PubMed ID: 27626923
[TBL] [Abstract][Full Text] [Related]
8. Adaptive down-regulation of the serotonin transporter in the 6-hydroxydopamine-induced rat model of preclinical stages of Parkinson's disease and after chronic pramipexole treatment.
Berghauzen-Maciejewska K; Wardas J; Kosmowska B; Domin H; Śmiałowska M; Głowacka U; Ossowska K
Neuroscience; 2016 Feb; 314():22-34. PubMed ID: 26628402
[TBL] [Abstract][Full Text] [Related]
9. The response to prolonged fasting in hypothalamic serotonin transporter availability is blunted in obesity.
van Galen KA; Booij J; Schrantee A; Adriaanse SM; Unmehopa UA; Fliers E; Schwartz GJ; DiLeone RJ; Ter Horst KW; la Fleur SE; Serlie MJ
Metabolism; 2021 Oct; 123():154839. PubMed ID: 34331964
[TBL] [Abstract][Full Text] [Related]
10. Brain dopamine and serotonin transporter binding are associated with visual attention bias for food in lean men.
Koopman KE; Roefs A; Elbers DC; Fliers E; Booij J; Serlie MJ; la Fleur SE
Psychol Med; 2016 Jun; 46(8):1707-17. PubMed ID: 26984412
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Obesity on the Availabilities of Dopamine and Serotonin Transporters.
Nam SB; Kim K; Kim BS; Im HJ; Lee SH; Kim SJ; Kim IJ; Pak K
Sci Rep; 2018 Mar; 8(1):4924. PubMed ID: 29563547
[TBL] [Abstract][Full Text] [Related]
12. Availability of dopamine and serotonin transporters in opioid-dependent users--a two-isotope SPECT study.
Yeh TL; Chen KC; Lin SH; Lee IH; Chen PS; Yao WJ; Lee SY; Yang YK; Lu RB; Liao MH; Chiu NT
Psychopharmacology (Berl); 2012 Mar; 220(1):55-64. PubMed ID: 21881874
[TBL] [Abstract][Full Text] [Related]
13. Quantitative autoradiography of ligands for dopamine receptors and transporters in brain of Göttingen minipig: comparison with results in vivo.
Minuzzi L; Olsen AK; Bender D; Arnfred S; Grant R; Danielsen EH; Cumming P
Synapse; 2006 Mar; 59(4):211-9. PubMed ID: 16385509
[TBL] [Abstract][Full Text] [Related]
14. Test-retest reproducibility of extrastriatal binding with
Matsuoka K; Yasuno F; Shinkai T; Miyasaka T; Takahashi M; Kiuchi K; Kosaka J; Inoue M; Kichikawa K; Hasegawa M; Kishimoto T
Psychiatry Res Neuroimaging; 2016 Dec; 258():10-15. PubMed ID: 27814458
[No Abstract] [Full Text] [Related]
15. Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder.
Hesse S; Müller U; Lincke T; Barthel H; Villmann T; Angermeyer MC; Sabri O; Stengler-Wenzke K
Psychiatry Res; 2005 Oct; 140(1):63-72. PubMed ID: 16213689
[TBL] [Abstract][Full Text] [Related]
16. Expression and co-expression of serotonin and dopamine transporters in social anxiety disorder: a multitracer positron emission tomography study.
Hjorth OR; Frick A; Gingnell M; Hoppe JM; Faria V; Hultberg S; Alaie I; Månsson KNT; Wahlstedt K; Jonasson M; Lubberink M; Antoni G; Fredrikson M; Furmark T
Mol Psychiatry; 2021 Aug; 26(8):3970-3979. PubMed ID: 31822819
[TBL] [Abstract][Full Text] [Related]
17. Changes in midbrain serotonin transporter availability in atypically depressed subjects after one year of psychotherapy.
Lehto SM; Tolmunen T; Joensuu M; Saarinen PI; Valkonen-Korhonen M; Vanninen R; Ahola P; Tiihonen J; Kuikka J; Lehtonen J
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):229-37. PubMed ID: 17884269
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Striatal Dopamine Transporter Binding in Individuals With Major Depressive Disorder: In Vivo Positron Emission Tomography and Postmortem Evidence.
Pizzagalli DA; Berretta S; Wooten D; Goer F; Pilobello KT; Kumar P; Murray L; Beltzer M; Boyer-Boiteau A; Alpert N; El Fakhri G; Mechawar N; Vitaliano G; Turecki G; Normandin M
JAMA Psychiatry; 2019 Aug; 76(8):854-861. PubMed ID: 31042280
[TBL] [Abstract][Full Text] [Related]
19. Chronic vagus nerve stimulation decreased weight gain, food consumption and sweet craving in adult obese minipigs.
Val-Laillet D; Biraben A; Randuineau G; Malbert CH
Appetite; 2010 Oct; 55(2):245-52. PubMed ID: 20600417
[TBL] [Abstract][Full Text] [Related]
20. Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian rats.
Conti MM; Meadows SM; Melikhov-Sosin M; Lindenbach D; Hallmark J; Werner DF; Bishop C
Neuropharmacology; 2016 Nov; 110(Pt A):125-134. PubMed ID: 27452719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
